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Abstract
By restricting the possible values of the proportion of null hypotheses that are true,
the local false discovery rate (LFDR) can be estimated using as few as one comparison.
The proportion of proteins with equivalent abundance was estimated to be about 20%
for patient group I and about 90% for group II. The simultaneously-estimated LFDRs
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give approximately the same inferences as individual-protein confidence levels for group
I but are much closer to individual-protein LFDR estimates for group II. Simulations
confirm that confidence-based inference or LFDR-based inference performs markedly
better for low or high proportions of true null hypotheses, respectively.
Keywords: confidence distribution; empirical Bayes; Lindley’s paradox; local false discovery
rate; multiple comparison procedure; multiple testing; observed confidence level; restricted
parameter space
1 Introduction
In the development of statistical methods for interpreting high-dimensional genomics data,
the challenges involved in analyzing genomics data sets of much smaller scale have been
largely overlooked, and yet such data are routinely generated. Out of the thousands of genes
in the human genome, the expression levels of only on the order of 30 genes are measured
in a real-time polymerase chain reaction experiment. Among the hundreds of thousands of
proteins in the human proteome, the abundance levels of only on the order of 200 proteins
are measured with mass spectrometry. The following idealization of the candidate-gene
approach to genetic association studies poses a problem encountered in analyzing data from
a small fraction of a large number of biological features, with each feature corresponding to
a different population in the sampling theory sense.
Example 1. Consider 106 populations such that Xi ∼ N (µi, 1) for i = 1, . . . , 106, where
µi = 2 for N1 values of i and µi = 0 for 106 −N1 values of i. None of the random values is
observed except x1, the realization of X1. The null hypothesis of interest is µ1 = 0. Let Φ
and φ respectively denote the standard normal distribution function and density function.
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Without any knowledge of N1, few would question the applicability of the p-value 1−Φ (x1).
On the other hand, in the absence of other information, the use of P (µ1 = 0;N1) = 1−N1/106
as an approximate, nonsubjective prior probability of the null hypothesis in order to obtain
the approximate posterior probability
P (µ1 = 0|x1;N1) = (1−N1/10
6)φ (x1)
(1−N1/106)φ (x1) + (N1/106)φ (x1 − 2) (1)
would not be controversial if N1 were known. Suppose that N1 is unknown but can be safely
assumed to be between 1 and 100. Then, for at least 99.99% of the populations, the null
hypothesis is true and thus 1− Φ (X1) ∼ U (0, 1). By contrast, for those same populations,
P
(
µ1 = 0|X1; N˜1
)
≈ 1 with high probability regardless of the value N˜1 between 1 and 100
that is guessed for N1 in computing the posterior probability. For instance, if x1 = 2, then
the p-value is 1−Φ (2) = 2.28% even though the posterior probability of the null hypothesis is
at least P (µ1 = 0|2; 100) = 99.93% and possibly as high as P (µ1 = 0|2; 1) = 1−7.39×10−6.
Lindley (1957) thoroughly examined a similar “paradox” from a more Bayesian viewpoint.
The type of problem faced in Example 1 will be attacked by adapting methodology
recently developed for gene expression microarray data to two other settings: (1) those with
data available for testing only a much smaller number of hypotheses and (2) those with much
smaller proportions of null hypotheses that are true.
Microarray technology enables the measurement of levels of gene expression for thousands
of genes in cells under two different conditions, conveniently labeled as treatment and control.
Which genes have differential expression in the mean between the treatment and control
populations? That large-scale problem of multiple comparisons led Efron et al. (2001) to
apply the false discovery rate (FDR) of Benjamini and Hochberg (1995) and to introduce
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the local false discovery rate (LFDR). In accordance with its name, the LFDR is a rate of
Type I errors that would be incurred were the null hypothesis rejected every time the same
data are generated as those actually observed. In the microarray context, the LFDR is an
empirical Bayes posterior probability of the null hypothesis that a particular gene does not
have differential expression, as in equation (1). More precisely, the LFDR is defined as the
prior probability of the null hypothesis conditional on the p-value or other statistic that
reduces the measured expression levels of the gene to a single number (Efron, 2010b).
Here, like in Example 1, the prior probability approximates an unknown proportion of
null hypotheses that are true, with each null hypothesis corresponding to a different gene. In
that sense, the LFDR differs from a fully Bayesian posterior probability, which requires the
complete specification of the prior distribution of all unknown parameters. Such specification
usually involves prior probabilities that correspond to hypothetical levels of belief rather than
real relative frequencies or proportions. Thus, whereas a purely Bayesian prior is necessarily
known in principle, empirical Bayes priors are unknown.
Since the LFDR generally depends on parameters that do not have a known prior dis-
tribution, the LFDR can only be estimated. Supposing, however, that the LFDR could be
known and neglecting any information lost in reducing the data to a test statistic for each
hypothesis, Bayes decision rules based on the LFDR would have optimal Bayes risk. That
is, they would perform at least as well on average as any other decision rule with respect to
any bounded loss function. Knowledge of the LFDR would require knowledge not only of
the proportion of null hypotheses that are true but also the distribution of the reduced data
under the alternative hypotheses. In that case, there would be no objection against relying
on the LFDR derived from Bayes’s theorem since frequentists by principle condition on the
data in the presence of a known population of parameter values (Fisher, 1973; Wilkinson,
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1977; Edwards, 1992; Kyburg and Teng, 2006; Hald, 2007, p. 36; Yuan (2009); Fraser, 2009).
With that knowledge, the unquestioned applicability of the LFDR would hold regardless of
the number of hypotheses that correspond to measurements. As a result, the LFDR would
apply to a single comparison corresponding to a hypothesis randomly drawn from the pop-
ulation (Example 1) no less than to multiple comparisons spanning the entire population of
hypotheses.
However, it is generally believed that the LFDR can only be adequately estimated if
there are data directly related to thousands of hypotheses. For example, if data are only
available for 20 genes, or, in the case study of this paper, 20 proteins, then the LFDR is not
considered applicable. Indeed, empirical Bayes methods designed for several thousands of
comparisons do not necessarily work as well with smaller numbers of hypotheses.
In some respects, that limitation of the empirical Bayes framework restricts the utility
of multiple comparison procedures more generally. The discussions of two empirical Bayes
papers spanning the last three decades (Morris, 1983a; Efron, 2010a) illustrate the consensus
that very different procedures seem suitable for different numbers of comparisons. Westfall
(2010) emphasized in his comment that whereas methods that control family-wise error
rates (FWERs) have insufficient statistical power for very large numbers of comparisons,
estimators of FDRs and LFDRs become unreliable for small numbers of comparisons. Efron
(2010c) replied with a recommendation for FWER control for smaller numbers of comparisons
as a substitute for empirical Bayes estimation of the FDR for larger numbers of comparisons.
That conflicts with the viewpoint of Morris (1983b), another pioneer of empirical Bayes
procedures, who resorted to fully Bayesian procedures for small numbers of comparisons.
The main purpose of this paper is to extend the scope of LFDR estimation to the smallest
possible scale: that of a single comparison. The investigation will involve modifying a
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successful method of LFDR estimation and studying its relative performance in various
contexts. It will be compared to fully Bayesian inference under a default prior and to the
p-value interpreted inferentially with the aid of confidence distributions. The importance
of the p-value in the multiple comparison framework lies in the fact that it is equal to the
p-value adjusted to control an error rate when only one comparison is made. For example,
with data for only a single hypothesis test, the achieved FDR, the lowest value at which the
FDR has guaranteed control, is equal to the p-value (Benjamini and Hochberg, 1995).
Were such a method of small-scale LFDR estimation available for small-scale genetic asso-
ciation studies, the widespread publication of significant findings that could not be replicated
(Morgenthaler and Thilly, 2007) might have been avoided. The reason is that LFDR esti-
mation takes advantage of an estimate of the proportion of null hypotheses that are true,
which is crucial for extremely small proportions, whereas p-values ignore that information,
thereby inflating the Type I error rate of testing a hypothesis picked at random.
Example 2. For testing hundreds of thousands of genetic variants for association with
disease, FWER control in the tradition of Bonferroni, Sidak (1967), and Holm (1979) often,
due to the large number of tests, results in the rejection of few or no null hypotheses. The
alarming number of false positives found in candidate gene studies (Morgenthaler and Thilly,
2007) at first seems to support such adjustments of p-values for the number of tests in order
to control an FWER. However, the analogous history of false positives in candidate-gene
studies (Ioannidis et al., 2001), in which much smaller numbers of tests were performed in
each study, shows that the number of tests is not the source of the high false-positive rate.
Rather, the root of the problem lies more in the small number of disease-associated variants
compared to the total number of variants, irrespective of how many happen to be measured.
Thus, many join the Wellcome Trust Case Control Consortium (2007) in questioning “the
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view that one should correct significance levels for the number of tests performed to obtain
‘genome-wide significance levels.” ’ In place of the number of tests performed, the Wellcome
Trust Case Control Consortium (2007) uses the proportion of variants that are associated
with disease as the prior probability of association, an approach that applies in principle
even to data representing only a single variant. That proportion is thought to be between
10−6 and 10−4, as in Example 1.
Section 2 introduces a parametric method that enables empirical Bayes inference even
in the absence of multiple comparisons. Next, Section 3 derives rival posterior distributions
from confidence intervals under fixed-parameter models. An application to proteomics data
illustrates the empirical Bayes and confidence methods in Section 4. Section 5 compares
the performance of the empirical Bayes and confidence methods for inference about a single
scalar parameter value that belongs to some population of parameter values. The paper
closes in Section 6 with a discussion of the resulting implications on whether empirical Bayes
or confidence strategies would be more suitable in a given context.
2 Empirical Bayes methods
While methods of estimating the LFDR on the basis of nonparametric density estimators
clearly cannot apply to single-comparison data (Efron, 2010b), it will be seen that fully
parametric methods of LFDR estimation by maximum likelihood can do so under suffi-
ciently simple models. Since the empirical Bayes models that define the LFDR have random
parameters, the likelihood is not maximized over their values but rather over the values of the
hyperparameters specifying the proportion of null hypotheses that are true and the distribu-
tion of the reduced data under the alternative hypothesis. Such parameters, if known, would
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entail knowledge of the LFDR (§1). More generally, the maximization of likelihood over
hyperparameters is called Type II maximum likelihood as opposed to the Type I maximum
likelihood of models that lack random parameters (Good, 1966).
2.1 Hierarchical sampling model
2.1.1 Level 1 of the model
Consider a reference set of N˜ populations that includes the N populations sampled. Thus,
N is the number of comparisons can be made on the basis of available data. For example,
N˜ may be the number of genes in the genome, whereas N is the number of genes on the
microarray that measures gene expression or is equal to 1 if the expression of only a single
gene is measured. Here, a comparison is understood as a hypothesis test or an effect-size
estimate.
Let Xi, an observable vector of dimension n, be a random variable of a distribution Pθi,λi ,
which depends on θi, the parameter of interest, and on λi, the nuisance parameter, for all
i ∈
{
1, . . . , N˜
}
. Similarly, model xj, the vector of n observations, as a realization of Xj for
all j ∈ {1, . . . , N}.
Those data are reduced as follows. A random statistic Ui is a function of Xi, and an ob-
served statistic uj is a function of xj, where the same function is applied to all i ∈
{
1, . . . , N˜
}
and to all j ∈ {1, . . . , N}. Thus, ui is a realization of Ui for all i ∈ {1, . . . , N}.
Supposing the distribution of Ui is indexed by the reduced parameter δi, a function
of θi and λi, its probability mass function or density function is denoted by f (•; δi) for
each i ∈
{
1, . . . , N˜
}
. It follows that the probability mass or density of ui is f (ui; δi) for
all i ∈ {1, . . . , N}. Without loss of generality, the ith null hypothesis is that θi = 0 or,
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equivalently, δi = 0, for any i ∈
{
1, . . . , N˜
}
.
Example 3. Suppose the expression level of each of N genes is measured for a total of
ntreat cell cultures treated with a chemical and ncontrol cell cultures not so treated. The
expression level of the ith gene is the logarithm of a measure of the abundance of mRNA in
the cells and is IID N (θtreati , λ2i ) within the treatment group and IID N
(
θcontroli , λ
2
i
)
within
the control group, λi being the common standard deviation. Then Ti, the equal-variance
Student t test statistic, has a noncentral t distribution with noncentrality parameter ∆i =(
θtreati − θcontroli
) (
1/ntreat + 1/ncontrol
)−1/2
/λi and n − 2 = ntreat + ncontrol − 2 degrees of
freedom; this is abbreviated by Ti ∼ Student (∆i, n− 2). Then Ui = |Ti| is very effective for
inference about δi = |∆i|. By implication, Ui is highly informative about the expression fold
change exp
∣∣θtreati − θcontroli ∣∣, the effect size most often estimated in reports of microarray data
analysis, and about whether θtreati = θcontroli since that is necessary and sufficient for δi = 0.
If ntreat +ncontrol is large enough, then Ti ∼˙ N (∆i, 1), which entails that U2i is approximately
distributed as χ2 (δ2i , 1), the noncentral chi-square distribution with noncentrality parameter
δ2i and 1 degree of freedom.
The most common model for analyzing genetic association data has the same asymptotics.
Example 4. Example 2, continued. In order to utilize genetic models such as the additive
model (Lewis, 2002) and in order to account for effects of covariates, genetic association data
are typically analyzed using the Wald approximation with logistic regression, yielding the
statistic Ti equal to the (Type I) maximum likelihood estimate of the log odds ratio divided
by the estimated standard error of that estimate for variant i of N . The statistic Ui = |Ti|
is highly informative about the absolute value of the log odds ratio and whether it is equal
to 0, as under the null hypothesis of no association between the genotype and the trait. For
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a sufficiently high number of case and control subjects, U2i ∼˙χ2 (δ2i , 1), as in Example 3.
2.1.2 Level 2 of the model
The first level of the hierarchical model describes the variability of the expression levels
of each gene or other population that corresponds to a comparison (§2.1.1). To represent
variability between populations or comparisons, δi is now modeled as the random variable
equal to 0 with probability pi0, equal to some δ(1) 6= 0 with probability pi1, equal to some
δ(2) /∈ {0, δ(1)} with probability pi2, ..., and equal to some δ(K) /∈ {0, δ(K)} with probability
for a K ∈ {1, 2, . . . }. The alternative-hypothesis parameters constitute ψ, a matrix with
〈pi1, . . . , piK〉 and
〈
δ(1), . . . , δ(K)
〉
as its two columns.
Then the unknown hyperparameters are pi0 and ψ, and the probability mass function or
density function of Xi is the finite mixture
f¯ (•; pi0, ψ) = pi0f (•; 0) +
K∑
k=1
pikf
(•; δ(k))
for all i ∈
{
1, . . . , N˜
}
. The random indicator νi will determine whether the null hypothesis
is true (νi = 1) or false (νi = 0) for all i ∈
{
1, . . . , N˜
}
. It is assumed that N˜ is large enough
that P (νi = 1) = pi0 is approximately
∑N˜
i=1 νi/N˜ , the proportion of null hypotheses that are
true.
The local false discovery rate, P (νi = 1|Ui = ui) by definition, is
LFDR (ui; pi0, ψ) =
P (νi = 1) f¯ (ui|νi = 1;pi0, ψ)
f¯ (ui; pi0, ψ)
=
pi0f (ui; 0)
f¯ (ui; pi0, ψ)
by Bayes’s theorem. As this LFDR is unknown only because pi0 and ψ are unknown, it may
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be estimated by Type II maximum likelihood, as will now be seen.
2.2 Type II maximum likelihood
The hyperparameters are estimated by pˆi0 and ψˆ, the values of pi0 and ψ at which the
likelihood
N∏
i=1
f (xi; pi0, ψ)
attains its maximum subject to the constraints that
∑K
k=1 pik = 1 and 0 ≤ pik ≤ 1. Then
LFDR
(
ui; pˆi0, ψˆ
)
is the maximum likelihood estimate of the LFDR. Pawitan et al. (2005),
Muralidharan (2010), and Yang and Bickel (2010) employed this method of estimating the
LFDR under fully parametric finite mixtures.
To prevent overfitting in the form of excessive variance in the estimates, the value of K
must be smaller for smaller values of N . For that reason, Bickel (2010d) suggested K = 1
when N < 1000. That model is simpler than those of higher values of K: the only free
parameters are pi0, the approximate proportion of null hypotheses that are true, and δ(1),
the value of the reduced parameter indexing the alternative distribution. However, it is not
simple enough for a single comparison (N = 1), for in that case, pˆi0 = 0 almost always.
More generally, whenever N is deemed too small for reliable estimation of pˆi0 with pi0
only restricted to the interval [0, 1], it will be further constrained to the strictly smaller
interval
[
pi−0 , pi
+
0
]
, a proper subset of [0, 1] with the specified bounds pi−0 and pi
+
0 such that
0 ≤ pi−0 ≤ pi+0 ≤ 1. Thus, the proposed method guarantees that pi−0 ≤ pˆi0 ≤ pi+0 even for the
lowest values of N .
In the case of N = 1, there is overfitting in the sense that pˆi0 = pi−0 almost always.
Likewise, for small values of N , ψˆ is not an optimal estimator of ψ. Thus, improvements
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such as those based on predictive distributions are certainly possible (e.g., Bickel, 2011).
Nonetheless, the application (§4) and simulations (§5) demonstrate that even the simple
method introduced here can perform substantially better than methods that take no account
of the hierarchical structure of the data. It will be seen that with certain distributions
of unknown parameter values, even extremely crude estimates of the hyperparameters are
preferable to no estimates at all.
To prevent problems with numerically maximizing the likelihood, the reduced parameter
δ(1) was constrained under the alternative hypothesis to have a lower bound of 10−3 for
Sections 4 and 5, but none of the results was sensitive to the value of that bound.
3 Confidence methods
This section confines attention to the single-level model consisting of the model of Section
2.1.1 with fixed parameters rather than the random parameters of Section 2.1.2. The con-
cept of confidence posterior distributions will be reviewed to set the stage for the observed
confidence levels to consider as viable alternatives to LFDRs.
Let Θ ⊆ R1 denote the parameter space of each fixed parameter value θi in the sense that
it is the smallest set in which θi is known to lie. Likewise, let Λ denote the parameter space
of each λi. Whereas the nuisance parameter λi may be a scalar or vector, it is assumed that
the interest parameter θi is a scalar, i.e., that Θ ⊆ R1.
Consider ϑi, the random variable that has probability distribution P (•;ui) on Θ such
that
P (ϑi ≤ θi;ui) = Pθi,λi (Ui ≥ ui) (2)
for all θi ∈ Θ and λi ∈ Λ, where Ui is a scalar statistic determined by Pθi,λi , the sampling
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distribution of Xi introduced in Section 2.1.1. The random elements of the equation are ϑi
on the left-hand side but Ui on the right-hand side.
The probability measure P (•;ui) is the confidence posterior distribution of θi. The word
confidence emphasizes the property that the interval bounded by the β1-quantile and the β2-
quantile of ϑi is a (β2 − β1) 100% confidence interval in the sense that it has a (β2 − β1) 100%
frequentist probability of including θi (Efron, 1993; Schweder and Hjort, 2002; Singh et al.,
2005). While the term posterior correctly indicates the dependence of the parameter distri-
bution P (•;ui) on the observed statistic ui (Bickel, 2010b,a), it is not necessarily a Bayesian
posterior, a conditional prior distribution given Ui = ui. For example, P (θ− ≤ ϑi ≤ θ+;ui)
is the confidence posterior probability of the hypothesis that the parameter of interest lies
between the fixed values θ− and θ+ and yet need not correspond to any Bayesian poste-
rior probability of the hypothesis. Polansky (2007) calls P (θ− ≤ ϑi ≤ θ+;ui) the observed
confidence level of the hypothesis; cf. Efron and Tibshirani (1998).
Example 5. Example 3, continued. For simplicity, the statistic is changed to Ui = Ti, which
is useful for inference about the value of θi = θtreati − θcontroli . Since Ti ∼ Student (∆i, n− 2),
equation (2) implies that ϑi/σˆi ∼ Student (ti, n− 2), where σˆi is the typical pooled estimate
of the standard error of the sample mean difference between treatment and control (Schweder
and Hjort, 2002). Thus, the confidence posterior distribution of the parameter of interest is
equivalent to the Bayesian posterior distribution resulting from the improper priors according
to which the mean and the logarithm of the standard deviation are uniform on the real line.
Coherence in the Bayesian sense would then require that the same posterior distribution be
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used for inference about |θi|, e.g.,
P (|ϑi| = 0; ti) = P (ϑi = 0; ti) = P (ϑi ≤ 0; ti)− lim
→0+
P (ϑi ≤ 0− ; ti)
= P0,λi (Ui ≥ ui)− lim
→0+
P0+,λi (Ui ≥ ui) = 0. (3)
For λi = 1 and large n, ϑ2i ∼˙χ2 (δ2i , 1), which Stein (1959) presented as the fiducial distribu-
tion for inference about θ2i , contrasting its interval estimates with confidence intervals.
The next example extracts a different confidence posterior distribution from the same
statistical model.
Example 6. Example 3, continued. Let Ui = |Ti| to draw inferences about θi =
∣∣θtreati − θcontroli ∣∣.
By equation (2), P (•;ui), the confidence posterior distribution of ϑi, is defined by
P (ϑi ≤ θi;ui) = Pθi,λi (|Ti| ≥ ui) .
Because Ti ∼ Student (0, n− 2) under the null hypothesis that θi = 0, the confidence poste-
rior probability that the null hypothesis is true is equal to the usual two-sided p-value:
P (ϑi = 0;ui) = P (ϑi ≤ 0;ui) = P0,λi (|Ti| ≥ ui) . (4)
This is a clear counterexample to the observation of Polansky (2007) and Bickel (2010b) that
many confidence posteriors e.g., that of Example 5, put no probability mass on any simple
hypothesis.
Like the Bayesian posterior, the confidence posterior can be used to make coherent deci-
sions given a loss function (Bickel, 2010b,a). In the metaphor of an intelligent agent, whereas
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the Bayesian posterior describes the decisions made by an agent committed to a particular
prior distribution, the confidence posterior describes the decisions made by an agent that
interprets confidence levels from a particular procedure as levels of certainty (Bickel, 2009).
Thus, the confidence posterior enables direct performance comparisons between frequentist
procedures and Bayesian and empirical Bayes posteriors, as will be seen in Sections 4 and
5.1.
4 Application to proteomics data
Alex Miron’s lab at the Dana-Farber Cancer Institute recorded the abundance level of each of
20 plasma proteins for every woman of two breast-cancer groups (55 HER2-positive women
and 35 mostly-ER/PR-positive women) and of a control group (64 healthy women) (Li,
2009). After adding the 25th percentile of the abundance levels within the control group to
all abundance levels in order to ensure that the adjusted levels were positive (Bickel, 2010d),
the logarithms of the adjusted levels of a given gene were modeled as quantities drawn from
a normal distribution with the same variance.
In comparing each breast-cancer group to the control group, the data for each protein
were reduced to the absolute value of the equal-variance t-statistic, which has a Student
t distribution under the null hypothesis of no difference between groups and a noncentral
Student t distribution with noncentrality parameter δ under the alternative hypothesis of a
nonzero mean difference, as in Example 3.
In order to analyze the data of all proteins simultaneously, it was assumed that the re-
duced data of all proteins with differential abundance levels are absolute values of variates
drawn from the same noncentral t distribution, the noncentrality parameter of which is
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denoted by δ. The assumption enabled computing pˆi0 and δˆ, the maximum likelihood esti-
mates of pi0 and δ, using the empirical Bayes method of Section 2.2 with the constraint that
0% ≤ pi0 ≤ 100%. For comparison, the data of each protein were then analyzed individually
by using the confidence and empirical Bayes methods as if it were the only protein with
measured expression.
The results are summarized in Figures 1 and 2. Within each figure, the posterior prob-
ability estimates of the top-left plot are the LFDRs estimated by substituting pˆi0 and δˆ for
pi0 and δ, with the vertical line specifying the value of pˆi0. Each posterior probability of each
top-right plot is the observed confidence level of the null hypothesis of equivalent abundance
between cancer and control groups as recorded by equation (4). The bottom two plots of
each figure report the LFDRs estimated separately for each protein by maximizing the like-
lihood with the constraints that pi0 ≥ 50% (bottom-left plot) and pi0 ≥ 90% (bottom-left
plot), with the vertical lines drawn at 50% and 90%, respectively.
Since only the top-left plot of each figure represents the simultaneous use of the data
for all proteins, it serves as the reference for evaluating the three methods of analyzing the
data of each protein in isolation from the other data. As seen in Figure 1, the observed
confidence levels closely match the simultaneously estimated LFDRs for the HER2-control
group. By contrast, the individual-protein LFDR estimates come much closer than the
observed confidence levels to the simultaneously estimated LFDRs for the ER/PR-control
group (Figure 2). The explanation for that difference between comparisons is that the
estimated proportion of equivalent-abundance proteins is low for the first group (pˆi0
.
= 22%)
but high for the second group (pˆi0
.
= 89%).
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Figure 1: Empirical distribution functions of the posterior probability that a given protein
has equivalent abundance between the HER2-positive and control groups. The four methods
compared are described in the text.
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Figure 2: Empirical distribution functions of the posterior probability that a given pro-
tein has equivalent abundance between the ER/PR-positive and control groups. Each plot
corresponds to a method described in the text.
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5 Simulation studies
The simulation studies of the following subsections were carried out in the scenario of Ti ∼
N (∆i, 1), Ui ∼ |Ti|, and δi = |∆i| since it represents the asymptotics of a wide variety of
situations encountered in practice, including those of protein abundance (§4), gene expression
(Example 3), and genetic association (Example 4). Specifically, the test statistics were the
absolute values of the realizations drawn from the normal distribution with mean δ = 0 and
variance 1 under the null hypothesis and from the normal distribution with mean δ ∈ {2, 4}
and variance 1 under the alternative hypothesis. The mean error in estimating the truth
of the null hypothesis (§5.1) or the rate at which interval estimates cover δ (§5.2) then
approximated the expected error or coverage probability of each single-comparison method
under the null and alternative hypotheses.
Such approximations enabled approximating the expected error and coverage probability
for any proportion pi1 of null hypotheses that are false as the weighted average of the expected
error or coverage probability with weight 1 − pi1 for the null hypothesis and pi1 for the
alternative hypothesis. This quantifies the average performance of applying each single-
comparison method to data drawn from a randomly selected hypothesis.
5.1 Hypothesis testing
The posterior probability that a method attributes to the null hypothesis is its estimate of the
value of the indicator νi that equals 1 if the null hypothesis is true or 0 if not (§2.1.2). Each
method’s estimation performance is here defined in terms of the mean squared error (expected
quadratic loss) for two reasons. First, admissibility under quadratic loss is necessary and
sufficient for certain desirable properties relevant to conditional inference (Robinson, 1979).
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Second, quadratic loss is the only proper scoring rule for probabilities that (a) depends
only on the difference between the estimator and estimand and (b) remains unchanged if
the estimator and estimand trade places (Savage, 1971). The square root of the expected
quadratic loss is easily interpreted as an average estimation error.
The present adoption of the confidence posterior probability of equation (4) is equivalent
to interpreting the p-value as an estimate of the indicator of whether the null hypothesis is
true. The p-value used this way does not require a significance threshold and can dominate
estimates defined to equal 0 if the p-value is below such a threshold and equal to 1 otherwise
(Hwang et al., 1992). Fixed-probability tails will be more appropriate for constructing the
confidence intervals of Section 5.2 since it, unlike the present section, in effect imposes a 0-1
loss function (Robinson, 1979).
On the basis of 100 realizations of the statistic drawn from each of the three normal
distributions N (0, 1), N (2, 1), and N (4, 1), Figures 3 and 4 compare the mean quadratic loss
of several methods of hypothesis testing in the general form of assigning posterior proba-
bility to the null hypothesis. The vertical lines are drawn at pi1 = 50%. The 0% posterior
probability represents any method that necessarily assigns no probability mass to the simple
null hypothesis, including improper-prior Bayesian updating and all other methods yielding
posterior density functions (Example 5). The observed confidence level is the confidence
posterior probability given by equation (4) with infinite degrees of freedom. Each of the four
methods of estimating the LFDR imposes a different constraint on pi0 when maximizing the
likelihood.
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Figure 3: Square root of the mean quadratic error of the (estimated) posterior probabilities of
null hypothesis truth versus pi1 = 1−pi0. Reduced data were simulated from the unit-variance
normal distributions of means 0 (true null hypothesis) and 2 (false null hypothesis).
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Figure 4: Square root of the mean quadratic error of the (estimated) posterior probabilities of
null hypothesis truth versus pi1 = 1−pi0. Reduced data were simulated from the unit-variance
normal distributions of means 0 (true null hypothesis) and 4 (false null hypothesis).
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5.2 Effect-size estimation
An interval estimate of the effect size |δ| is the interval between two quantiles of a posterior
distribution of |δ|, whether a confidence posterior, a Bayesian posterior, or an empirical
Bayes posterior. For example, the central or equal-tail (1− α) 100% confidence interval
corresponding to a confidence posterior is the interval between its α/2 and 1−α/2 quantiles.
The coverage rate of an interval estimate is its probability of including the true value of the
interest parameter, |δ| in the case of the simulation studies.
Figure 5 displays the coverage rates of the equal-tail 95% interval estimates for simulating
800 observed test statistics from the null distribution and another 800 from the alternative
distribution with δ = 2. The displayed coverage rates are visually indistinguishable from
those instead using 800 draws from the δ = 4 distribution.
The six posterior distributions of Figure 5 are those of Section 5.1, again with the vertical
line at pi1 = 50%. The improper Bayesian posterior induced by the uniform prior distribution
of δ represents the class of 0%-posterior methods (Example 5). Its interval estimates were
criticized by Stein (1959) and Wilkinson (1977) in favor of the confidence intervals of Figure
5. Its assignment of 0% posterior probability to the null hypothesis is evident from equation
(3).
6 Discussion and conclusions
The proposed method of constraining pi0 requires no more subjective input than the popular
methods of estimating the LFDR that rely on nonparametric density estimation: they depend
on the assumption that pi0 be greater than about 90% (Efron, 2004). With sufficiently high
choices of pi0, all such methods tend to be conservative.
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Figure 5: Proportion of 95% interval estimates that include the true value of the mean versus
pi1 = 1 − pi0. Reduced data were simulated from the unit-variance normal distributions of
means 0 (true null hypothesis) and 2 (false null hypothesis). The 50-100% and 90%-100%
curves coincide.
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The objection may be raised that all such choices are unnecessary given the guaranteed
coverage rates of fixed-parameter confidence intervals. Indeed, although Bayesian and em-
pirical Bayes methods can cover the true parameter at slightly higher rates, they can also
have much worse coverage than confidence intervals. For example, empirical Bayes intervals
based on LFDR estimation have poor coverage at high values of pi1 (Figure 5).
However, the main advantage of LFDR-based interval estimates over fixed-parameter
confidence intervals lies not in the potential increase in the coverage rate but rather in the
striking reduction in their width (Ghosh, 2009; Efron, 2010b; Bickel, 2010c). That is espe-
cially true for lower values of pi1, as can be seen from the greater and greater concentration
of posterior probability mass at the null hypothesis as pi1 → 0 (Figures 3 and 4). When-
ever the posterior probability of the null hypothesis is at least 97.5%, which happens with
close to 100% frequency for high values of the lower bound pi−0 , the 95% interval estimate is
[0, 0]. That interval has zero width and yet will cover the true value at a rate of 1− pi1, the
proportion of null hypotheses (θi = 0) that are true.
The value of pi1 also determines whether the LFDR approach performs better or worse
than the confidence approach in the context of inferring whether or not a null hypothesis is
true. For pi1≤˙10%, there is substantial improvement in inference even when pi−0 is far from
1− pi1 (Figures 2, 3, and 4).
Among others, Lindley (1957) and Berger and Sellke (1987) contrasted Bayesian posterior
probabilities of simple null hypotheses with p-values before the LFDR was defined. The
results of Berger and Sellke (1987) hold without their reliance on the misinterpretation of
the p-value as a Bayesian posterior probability since, in confidence-posterior decision theory
(Bickel, 2010b,a), the two-sided p-value can be a legitimate confidence posterior probability
(4). Berger and Sellke (1987) found that the p-value can be far from the actual error rate,
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which necessarily depends on pi1, the proportion of null hypotheses that are false, whether
or not that proportion is known. That, however, is insufficient for concluding that Bayesian
testing is superior: in low-information situations, Bayesian posterior probabilities will also
be far from those that would be computed with knowledge of pi1 and other model parameters.
For the practical scientist who does not want to know about error rates but instead whether
or not the null hypothesis is true, the more important criterion is whether Bayesian posterior
probabilities or p-values come closer to νi, the indicator of the truth of the ith null hypothesis.
Using that criterion actually favored the p-value as an observed confidence level over
the empirical Bayes methods for pi1≥˙50% (Figures 1, 3, and 4). That largely vindicates the
use of confidence-based methods when all that is known about the parameter of interest is
encoded either in the model or in the test appropriate for a plausible null hypothesis (§3).
Nonetheless, even with the vague information that the hypothesis tested belongs to a
relevant class in which most null hypotheses are true, rough guesses at pi−0 can bring notable
improvements in inference accuracy. An extreme case is that of genetic association studies
(Example 2), for which pi−1 = 10−6 and pi
+
1 = 10
−4 are reasonable lower and upper bounds
of the proportion of SNPs associated with a given disease (Wellcome Trust Case Control
Consortium, 2007).
The need to consider pi1 when making statistical inferences cannot be avoided by run-
ning algorithms that automatically control the FDR or FWER. The fundamental difference
between the LFDR and the FDR is exposed at lower numbers of comparisons and especially
at the single-comparison scale. Since FDR control reduces to standard hypothesis testing
when there is only a single test (Benjamini and Hochberg, 1995), the achieved FDR, like
any achieved FWER, is the unadjusted p-value and thus is suitable in the same high-pi1
situations.
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